Methotrexate-associated lymphoproliferative disorder of the stomach presumed to be mucosa-associated lymphoid tissue lymphoma

Sho Ishigaki, Tatsuhiro Masaoka, Hisako Kameyama, Miho Kawaida, Kaori Kameyama, Takehiko Mori, Takanori Kanai

研究成果: Article

1 引用 (Scopus)

抜粋

The number of patients with methotrexate-associated lymphoproliferative disorder (MTX-LPD) is increasing. We describe a case of MTX-LPD of the stomach. After treatment with methotrexate for rheumatoid arthritis, the patient developed left cervical lymphadenopathy and an ulcerative lesion in the stomach, which was presumed to be a mucosa-associated lymphoid tissue (MALT) lymphoma. However, we suspected MTX-LPD, based on the clinical course and the positivity of in situ hybridization for the detection of the Epstein-Barr encoding region. After the cessation of MTX, the left cervical lymphadenopathy and the gastric lesion disappeared. This is first report of gastric MTX-LPD that was presumed to be MALT lymphoma.

元の言語English
ページ(範囲)3249-3254
ページ数6
ジャーナルInternal Medicine
57
発行部数22
DOI
出版物ステータスPublished - 2018

ASJC Scopus subject areas

  • Internal Medicine

フィンガープリント Methotrexate-associated lymphoproliferative disorder of the stomach presumed to be mucosa-associated lymphoid tissue lymphoma' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用